chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever, redness, swelling to injection site site measuring 13 1/2cm by 10 1/2 cm
Site: Pain at Injection Site-Severe, Additional Details: Patient called 02/01/2022 to report pain from pfizer vaccine given 08/24/2021. Patient reported the day following injection of adverse events.  Patient symptoms included pain at injection site, entire arm pain, trouble moving arm, unable to raise arm higher than previous, dull pain and aches, pain upon awakening in morning, and trouble sleeping do to pain.  Patient is still experiencing pain.
This spontaneous report as received from a healthcare worker (also reported as office manager) refers to a female patient of unknown age. Approximately on 14-MAR-2013 (reported as 14-MAR-2013 or 15-MAR-2013) the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date and route not reported). Approximately on 20-MAR-2013 (reported as over the weekend) this patient developed fever blisters. The patient was given VALTREX for the event. Patient sought medical attention by contacting the Health Care Professional (HCP). The outcome of the event was reported as unknown. Causality was not reported. Additional information has been requested.
Complain of feeling dizzy, nauseous, numbness, pain in arms and legs bilaterally. no other symptoms, 98% oxygen, pulse 71,  no breakfast prior to vaccine, symptoms resolved. no EMS needed. observed for 30 minutes
2nd dose was more tired and itchy; 2nd dose was more tired and itchy; Hives; This is a spontaneous report from a contactable consumer (the patient) received from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of   BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on an  unspecified date as a SINGLE DOSE for covid-19 vaccination. Historical data includes patient received Dose 1 (got tired and was itchy).   The patient medical history and concomitant medications were not reported.  On an unspecified date , The patient experienced  2nd dose was more tired and itchy and had  hives. Consumer wants to know if she should go the Emergency Room 'waited 3 min and cold transferred to D&S Pfizer CEP 2191'. The clinical outcome of the events fatigue, itchy and hives was unknown.   Information about Batch/Lot number has been requested.
normal body aches and lethergy  Thursday and Friday. Saturday chest pain and jaw pain neck pain loss of vision especially in the right eye worse headache/migraine  sweating  elevated ddimer results.
Patient called 2 days after receiving her vaccine to report she started experiencing side effects exactly 24 hours post-vaccination.  On the night of 11.09.2023, patient noticed severe bruising at the site of injection and noticed the spot was also warm to the touch.  She said the area had a "double-quarter sized bruise."  She noted she had full mobility with her arm, but that it was still sore.  When asked if symptoms were worsening, patient said, "they were staying the same."  Patient has not contacted her doctor.
Reddened rash on face, arms, legs, and torso. C/o itching all over. Few hives noted on face and legs.
TENDERNESS IN THE CHEST; LUNG INFLAMMATION; COUGHING; SORENESS; TROUBLE BREATHING; THROAT SWELLING; CHEST TIGHTNESS; GENERAL SWELLING; DETERIORATION; DID NOT FEEL WELL; TIRED/FATIGUE; This spontaneous report received from a patient concerned a 43 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1805020, and batch number: 1805020 expiry: 25-MAY-2021) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 29-APR-2021, the subject experienced tired/fatigue. On MAY-2021, the subject experienced deterioration. On MAY-2021, the subject experienced did not feel well. On 07-MAY-2021, the subject experienced soreness. On 07-MAY-2021, the subject experienced trouble breathing. On 07-MAY-2021, the subject experienced throat swelling. On 07-MAY-2021, the subject experienced chest tightness. On 07-MAY-2021, the subject experienced general swelling. On 07-MAY-2021, the subject experienced coughing. On 08-MAY-2021, the subject experienced tenderness in the chest. On 08-MAY-2021, the subject experienced lung inflammation. The action taken with covid-19 vaccine  was not applicable. The patient was recovering from tired/fatigue, had not recovered from soreness, trouble breathing, throat swelling, chest tightness, general swelling, lung inflammation, and coughing, and the outcome of tenderness in the chest, did not feel well and deterioration was not reported. This report was non-serious.
PT received Pneumovax on left thigh dim on 02/17/2003. Mom called stating 02/17/2005 pt lrg swollen, red, and pt could not walk.
vaccine expired on 7/13/2022  used in clinic 7/15/2022 none reported as of 8/5/2022
Pain, redness, warmth spreading since vaccine given. Right thigh with injection site surrounded by about 1cm of induration and about 3cm of erythema.
Received Pfizer booster on 10/11/21 and have had vestibular/vertigo symptoms since then requiring constant treatment for nausea and management of symptoms as well as multiple medical appointments with primary care, physical therapy, neurology, ENT, A significant impairment to my quality of life.
Day of immunization: Pain at injection site preventing sleep approximately 10pm, so took two extra strength TYLENOL. Day after immunization: Woke up at 3:30am with moderate pain at injection site, but shivering, thirsty, no appetite, no energy, and temperature of 100.7 degrees. At approximately 0530 took two more extra strength TYLENOL and will attempt to go back to sleep.
ERYTHEMA & INDURATION 1 X 1.5 IN OVER RIGHT ARM (PCV7) NO TREATMENT EXCEPT FOR WARM COMPRESSES.
COVID-19; COVID-19; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 28 patients. This is one of 28 reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced COVID-19 (medically significant) on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on unknown date. The reporter stated that 28 people from a certain location tested positive.  The lot number for bnt162b2 was not provided and will be requested during follow-up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101237061 Same reporter/product/events, different patient
Extremely late period   Severe period symptoms but no period from April 14-May 1st
BECAME "VERY SICK" WITH "SEVERE MUSCLE ACHES" ,COUGH,CHILLS,HEADACHE, FEVER AT 7 HOURS POST VACCINE. STATES HE WAS UNABLE TO WORK THE NEXT 2 DAYS . HE TOOK TYLENOL 3 ON THE DAY AFTER THE VACCINE AND INTO DAY 2 AFTER THE VACCINE . TOOK IT EVERY 4-6 HRS. HE RETURNED TO WORK ON 1/14/2021 AND IS SYMTOM FREE NOW.
Breakthrough COVID case. Fully vaccinated with booster dose. Immunocompromised. Incomplete information regarding lots for vaccines, above is all we have.
COVID vaccine adminsitered 7/15/21, cellulitis noted at point of administration with initiation of treatment on 7/20/21. 10 day course of IV Vancomycin completed. Resident suffered no other adverse reactions.
Pt called 3 days after DTAP given. R arm had 7 X 8cm induration, erythema with heat provider treated with Zithromax 200mg/5ml sysp 7ml qd X 5 days. On 5/8/06, follow-up again. 5/10/06 by another doctor who gave another medication.
Two days after receiving Fluad vaccine, patient experienced violent shaking, chills, and diarrhea.
Every time, it itches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 83-year-old female patient received BNT162b2 (BNT162B2), on 06Jul2021 as dose 2, single (Batch/Lot number: unknown) at the age of 83 years for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE.), for Covid-19 Immunisation, reaction(s): "every time, it itches". The following information was reported: PRURITUS (non-serious), outcome "unknown", described as "Every time, it itches". Additional information: Other Conditions, Investigations and other product was No. States she is using an unspecified itch cream. Reporter has no dates or Lot Numbers available for any of her previous doses of the COVID Vaccines. Reporter does not recall how many COVID Vaccines she has had over time. Mentions that every time, it itches. Caller mentions having her second dose of the COVID Vaccine, she thinks, on 06Jul2021. Reporter denies any concomitant medications. Reporter then states that she had some unspecified pill the doctor gave her and then said it is bad for the caller's brain. No further information provided related to this unspecified pill. Reporter denies any medical conditions relevant to report. History and Investigations, Reporter denies any labs, testing, or treatments to report relevant to these events.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201322724 same reporter/patient/event, diffrent drug dose;US-PFIZER INC-202201322508 same reporter/patient, diffrent drug dose/event.
Pt recv vax on 8/27/97; on 5/3/99 pt exp varicella
Severe h/a starting 1 hrs p/inject dizziness & low grade temp for about 24 hrs;
patient called in pharmacy 11:35 am on 5/4/21 and told that she had gotten seizures 2 times yesterday night on 5/3/21 at 9pm and 10:30pm.  she went to ER and got injection. she will see neurologist to check overall. she states she missed seizure meds few times recently.
Shortness of breath, pulse oxygen dropped below 75, hospitalization for 7 days, given prednisone for 3 months to raise pulse oxygen, 100% gro7nd glass found in CT scan high res, still shortness of breath with any exertion or climbing stairs. 60% lung capacity left.
HIP PAIN; This spontaneous report received from a patient via a company representative through social media  concerned a female of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 01 total administered for covid-19 prophylaxis.  It was unknown whether the patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1). The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) dose, start therapy date were not reported, 01 total, administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced hip pain for two years (Dose number in series 2). It was reported that the doctors could not figure it out. The patient had to use walker at one point.  It was reported as "[Name redacted] I have had hip pain for two years. Doctors can't seem to figure it out. Had to use walker at one point. Had vaccine and one booster. I am done with vaccines. Wouldn't have had any but got tired of husband hounding me". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hip pain. This report was non-serious.
1/5/20 @ 1:30 pm symptoms of systemic itching, itching in throat, throat irritation, lightheadedness, nausea and increased phylum in throat.
Arm red, swollen, warm Narrative: Reports injection site redness increasing since time of vaccination. Injection site is swollen and warm. Has been doubling in size since vaccination.
Heaviness, aching, large hardened area under the skin, warm to touch (Left Arm).
Headache, swelling/redness/pain at injection site, muscle/joint pain, shivering, malaise
This spontaneous report was received from a medical assistant refers to unspecified patients of unknown age and gender. There was no information on concomitant medications, medical history and concurrent conditions.  On unknown dates, unknown number of patients were vaccinated with improperly stored GARDASIL 9 via intramuscular route, lot# M031557, expiry: 07-APR-2017 for prophylaxis. The vaccine was stored at a temperature below 36F (2C) but above 32F (0C) (33F) for 46hours 30 min. There was no previous temperature excursion. Data logger was involved. No product quality complaint was involved. No further information was provided. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1702USA011404:
for his back pain; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team and from a Pfizer sponsored program, COVAX US Support. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) as first dose, single dose for COVID-19 immunisation and ibuprofen, route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient's medical history and concomitant medications were not reported. Patient was asking if he can take aspirin or Tylenol or ibuprofen or diclofenac? On 13Mar2021, the patient claimed that he has not taken any medication yet and asked if he can take Tylenol or Aspirin for his back pain. The action taken in response to the event for ibuprofen was unknown. The outcome of the event was unknown.  No follow-up attempts are needed. No further information expected.
Pain, muscle weakness in right arm, confirmed by Dr. via nerve conduction studies.  Little improvement since onset.  Diagnosis of Parsonage Turner Syndrome / Brachial Myopathy.
hyperpigmented papule at injection site; ~0.25 cm diameter hematoma under skin
PATIENT CLAIMS THAT SHE FELT A DROP DRIPPING ON HER ARM DURING VACCINATION. PHARMACISTS EXPLAINED THAT THERE COULD BE A LEAKAGE DURING ADMINISTRATION; HOWEVER, SHE STILL RECIEVED FULL DOSE. ALSO, PATIENT CLAIMED THAT SHE FELT DIZZY AND LIGHTHEADED AT CHECK-OUT AFTER MORE THAN 2 HOURS OF SHOPPING WHICH INCLUDED CONTINUOUS WALKING, LIFTING ITEMS, BENDING, AND MULTIPLE SUDDEN TEMPERATURE CHANGES AT FROZEN ISLE. VACCINES WERE GIVEN AT 01:54PM AND SHE FELT LIGHTHEADED AT 04:03PM.
Present vesicles and papules on buttocks, inner thighs. Lesions lower legs some on pharynx.
numbness on face and tongue, pain on both sides of kidney area, headache darker orange urine, joint pain specially still have pain on knees joints and they make noise when bending.
First time ever Ear infection lead to vertigo for over 13 hours on March 7, 2021. Spotting on July 18, 2021 - last menses was on or about August 1, 2018.
FLUCELVAX GIVEN TO PERSON LESS THAN 18 YEARS OLD.  NOT FDA APPROVED FOR PATIENTS AGE.  NO IMMEDIATE ADVERSE OUTCOMES REPORTED.
clotting, PE RLL seg and subseg, L calf vein, R SCV, brach and ax v, radial art, bleeding aneurysmal at T10, w/ assoc thrombus and poss myelitis, e/o SAH My plan is agree w/ IVC filter, and holding AC at this time, would avoid further covid vaccines w/ quite extensive clotting w/in wks of getting booster, unexpected w/ his prior hx, though his mom did die of a stroke in her late 80s  The patient was admitted and the following issues were addressed during this hospitalization: (with pertinent details including admission exam/imaging/labs).  12/15: Transferred from hospital for non-aneurysmal SAH/IVH 12/16: CT head/ MRI head ordered 12/17: Distal R radial artery occlusion, IR and Vascular surgery consulted 12/20: Extubated. Alkalotic, not tolerating so reintubated. CTA showing PEs. PERT activated. AFIB with RVR - metoprolol and cardizem. Blood cultures sent and antibiotics widened 12/21: IVC filter placed in IR. Heme consulted. ID workup. 12/22: CT head. Antibiotics stopped.  12/27: Trach at bedside 12/28: MRI T-spine, PEG tube in IR 12/30: Trach shield.  1/3: Progressed to tele status. PT/OT/SLP involved.  1/5 Rehab Medicine consulted.  1/6: Trach removed by patient. involved; working towards placement.  1/18: Discharged to facility with plan to see in 1 month with repeat imaging of spinal AVM
Inappropriate dose administered; Inappropriate dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of underdose in a 54-year-old male patient who received HAV (Havrix 720) (batch number D7HA9, expiry date 27-OCT-2024) for prophylaxis.   On 07-JUN-2023, the patient received Havrix 720. On 07-JUN-2023, an unknown time after receiving Havrix 720, the patient experienced underdose (Verbatim: Inappropriate dose administered) and adult use of a child product (Verbatim: Inappropriate dose administered). The outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK receipt date: 12-JUN-2023 The reporter consented to follow-up. An adult patient received a dose of Havrix 720, which led to underdose and adult use of a child product.
One day after injection in left thigh- Injection site- swollen warm to touch. ibuprofen and cool compresses given
Fever, weakness and hives on arms, thighs and legs, lasting more than a week so far.
37y female with history of anxiety disorder who presents to ED with chief complaint of feeling shaky, hot, and racing heart after receiving 1st dose of Moderna COVID-19 vaccine. Patient reports receiving injection, subsequently walking to the check out line and suddenly feeling hot, tremulous, and tachy. She endorses tingling and numbness in bilateral upper extremities, diaphoresis, heart palpitations, and blurry vision. She denies HA, n/v chest pain, SOB, hemoptysis, syncope, loss of consciousness, bowel incontinence, and bladder incontinence, HR improved, patient left ED with no concerns
she was vomiting; fever of 100.7; Felt like she had the flu; hurting all over her body; This spontaneous report was reported was received from a consumer and concerning in a 71-year-old,female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) and experienced of vomiting, high fever of 100.7, hurting all over her body and Felt like she had the flu.    The patient's past medical history included No adverse event.  Concomitant products included Acetoaminophen from 23-Mar-2021 to an unknown date, Ondansetron from 23-Mar-2021 to an unknown date, Metoclopramide and Sodium chloride 0.9% Dextrose5 % from  23-Mar-2021 to an unknown date.  Treatment included Fluids given at the ED   On 22-Mar-2021,prior to the onset of event s the patient received the second of two planned dose of mRNA-1273 Moderna COVID-19 Vaccine (Batch number:003A12A) Intramuscularly in the arm for prophylaxis of COVID-19 infection.  The patient was hospitalized on 23-Mar-2021 due to fever and Vomiting. The patient also experienced hurting all over her body, Felt like she had the flu.  Action taken with mRNA-1273 in response to the events was not Applicable.   The outcome of events vomiting, high fever of 100.7, hurting all over her body and Felt like she had the flu was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
pt recv vax 16JUL98 & 31JUL98 pt devel joint pain in legs;3AUG98 pt exp numbness, tingling & pain in fingers;5AUG98 MD felt that adverse exp were r/t therapy w/rubella vax;
Pfizer Covid-19 age 5-11y/o was administered to 15y/o as a booster, DOB on consent was incorrect. Vaccinator didn't confirm age.
Student c/o feeling like wanted to vomit, feeling faint, pale. Mom reports student has not eaten she has had this reaction 1 year ago cold pack, pretzels and water.
stabbing pain under left scapula on second morning, getting stronger daily until Monday ( 7 days after vaccination) when pustules erupted that morning. diagnosis was shingles. severe pain after anti-viral treatment resulted in further medication for nerve pain. pain manageable after 4 weeks of pain treatment.
Patient complained of sharp chest pain, she took some tums and it turned to a dull ache.  Patient's blood pressure was slightly elevated for her at 133/88.  After about 5- 10 minutes her chest pained turned to a tightness, then she started to feel better.
Swollen arm where vaccine was administered, she has reported cellulitis and is receiving IV antibiotics.
HOSPITALIZATION RELATED TO COVID-19 FOLLOWING COMPLETION OF PRIMARY COVID VACCINE SERIES
Patient developed a swollen, raised, red nodule on left arm in deltoid region of vaccine administration on 10/6. Later that day, patient developed a fever, and went to MD's office and received antibiotics for diagnosed cellulitis in left arm. Patient continues to take antibiotics at the time of this report and is reported today to be feeling a bit better.
Case number PHEH2013US025173, is an initial spontaneous report received from a physician on 03 DEC 2013. This report refers to a 16-year-old female patient. She received only Men C, Y, W-135 liquid conjugate component of MENVEO (batch number: M12104), intramuscularly without being reconstituted with Men A lyophilized conjugate vaccine component on 21 NOV 2013. No adverse event was reported following this administration error.
patient was administered from an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.   In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered from an expired vaccine) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient administered expired vaccine which was initially stored on 04-Nov-2021 patients were administered with dose in which some vaccinated on 05-Nov-2021 and 12-Nov-2021. The vial did not undergo any temperature excursions.HCP stated, no adverse event occurred as result of this misadministration, patients were monitored.  No Treatment medications were reported.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration on an unspecified date as an unspecified dose for an unspecified indication. The patient medical history was not reported. The patient's concomitant medications were not reported. On 20Jan2021, the patient experienced tested positive for covid. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 20Jan2021. The action taken in response to the event for bnt162b2 was not applicable. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.
dizzy, chills, headache, sweating, severe pain in chest, went to hospital by ambulance.